Text Size

Cost-utility analysis of latanoprost unidose cationic emulsion preservative-free versus latanoprost unidose in the treatment of open-angle glaucoma and ocular hypertension patients in Spain

Canut MI, García-Feijoo J, Larrosa-Poves JM, López-López F, Pazos M, Espinoza-Cámac N, Oyagüez I, Del Rio T, Rodríguez M.


  • 2025
  • Expert Rev Pharmacoecon Outcomes Res
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Disease understanding (epidemiology, diagnosis, QoL, Biomarkers…)

  • Affiliations

    Oftalvist Clinic, Barcelona, Spain. Department of Ophthalmology, Hospital Clínico San Carlos, Madrid, Spain; Instituto Ramón Castroviejo, Universidad Complutense, Madrid, Spain. Department of Ophthalmology, Hospital Miguel Servet, Zaragoza, Spain; Department of Ophthalmology, Hospital Clínico de Santiago, Santiago de Compostela, Spain; Instituto Oftalmológico Gómez-Ulla, Santiago de Compostela, Spain; Institut Clínic d'Oftalmologia, Hospital Clínic de Barcelona, Barcelona, Spain; Pharmacoeconomics & Outcomes Research Iberia (PORIB), Madrid, Spain; Santen Pharmaceutical, Madrid, Spain.

Related Publications

Associations between Clustered Visual Field Progression and Locations of Disc Hemorrhages in Glaucoma: A 3-Year Prospective Study

Akagi T, Fukuchi T, Higashide T, Udagawa S, Ohkubo S, Sugiyama K, Tanihara H, Araie M, Tomita G, Matsumoto C, Tomidokoro A, Hangai M, Kawata H, Inai M, Tanaka Y; SVF Prospector Study Group.


Felodipine re-positioned as a neuroprotectant via improved optic nerve head blood circulation in retinal ischemic rabbits and ocular hypertensive rats

Taniguchi T, Akaishi T, Hata T, Yamashita R, Esaki Y, Morofuji R, Okabe K, Fuwa M, Yamamoto Y, Guo L, Choi S, Luong V, Ota T, Sharif NA, Cordeiro MF, Kageyama M.


A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

Konstas A.G.; Garhöfer G.; Lübke Y.; Voykov B.; Ropo A.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022